David S. Memel, MD, MS, MBA





Dr. Memel joined Metabolon in 2017 as Chief Medical Officer and is responsible for providing medical leadership in developing and delivering the company’s Precision Medicine products.

He has over 25 years of leadership, innovation and operating experience in multinational pharmaceutical, diagnostics, provider and payer organizations. Prior to joining Metabolon, Dr. Memel was the Managing Director of Klaipeda Health, a healthcare and life sciences advisory company. Before Klaipeda Health, he held a variety of commercial, medical, scientific, informatics and technology leadership positions at Boehringer Ingelheim Pharmaceuticals, Aetna, Roche Diagnostics, Roche Pharmaceuticals and PeaceHealth. Dr. Memel began his career as a diagnostic and interventional radiologist. He received his B.S. and M.D. from the University of California at Los Angeles, an M.S. in medical informatics from the University of Utah, and a dual M.B.A. from Cornell University and Queen’s University in Canada. Dr. Memel also completed a Fellowship in clinical effectiveness research at the Harvard School of Public Health.